Anticholinergic drugs for parkinsonism and other movement disorders
Journal of Neural Transmission · 2024
DOI: 10.1007/s00702-024-02799-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, 2024. Verfasst von Peter A LeWitt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, 8-D 4201 St. Antoine Street, Detroit, MI, 48201, USA. aa…. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Movement Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Anticholinergic (AC) drugs, a medication class that acts by blocking nicotinic and muscarinic acetylcholine receptors, were first utilized for therapeutic purposes in the mid-19th century. Initial applications were as symptomatic therapy for Parkinson disease (PD), a practice continuing to the present. Initially, the AC drugs used were naturally-occurring plant compounds. Synthetic AC drugs were developed in the late 1940s and predominated in neurological therapeutics. Until the advent of pharmaceuticals acting upon striatal dopaminergic motor pathways, AC drugs provided the only effective means for lessening tremors and other clinical problems of the PD patient. However, because dopaminergic compounds are so effective at meeting the needs of the typical PD patient, AC medications are far less utilized by clinicians today. In recent years, there has been only a few investigations of AC drugs as neurological treatments. This review will revisit the clinical landscape of AC pharmacology and application for movement disorders along with recent research in search of improving therapeutics with AC drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, 8-D 4201 St. Antoine Street, Detroit, MI, 48201, USA. aa1142@wayne.edu.
- The Department of Neurology, University of South Florida, Tampa, FL, USA.
- Department of Pharmacology and Therapeutics, Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA.
ORCID-Profile: Peter A LeWitt
Förderung
- NINDS NIH HHS
Zitieren
APA
LeWitt, P. A., Hong, L., & Moehle, M. S. (2024). Anticholinergic drugs for parkinsonism and other movement disorders. Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02799-7
Vancouver
LeWitt PA, Hong L, Moehle MS. Anticholinergic drugs for parkinsonism and other movement disorders. Journal of Neural Transmission. 2024. doi:10.1007/s00702-024-02799-7
BibTeX
@article{LeWitt2024,
author = {LeWitt, Peter A and Hong, Luke and Moehle, Mark S},
title = {Anticholinergic drugs for parkinsonism and other movement disorders},
journal = {Journal of Neural Transmission},
year = {2024},
doi = {10.1007/s00702-024-02799-7}
}
EUVIMED